---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-006512"
form_type: "8-K"
ticker: "TECH"
cik: "0000842023"
company_name: "BIO-TECHNE Corp"
filed_at: "2025-05-06T23:59:59+00:00"
generated_at: "2026-05-22T15:43:30.189084+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Bio-Techne authorizes $500M share repurchase program, replacing prior 2022 authorization

## Summary
- Board authorized up to $500M in common stock repurchases on April 30, 2025.
- Replaces the prior $500M program approved February 2, 2022; no expiration date set.
- Repurchases may be made in open market, private transactions, or block trades.
- Management retains discretion based on market conditions, stock price, and capital needs.
- Program intends to offset dilution from stock option exercises among other purposes.

## SEC filing metadata
- accession: 0001558370-25-006512
- form_type: 8-K
- ticker: TECH
- cik: 0000842023
- company_name: BIO-TECHNE Corp
- filed_at: 2025-05-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/842023/000155837025006512/0001558370-25-006512-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/842023/000155837025006512/tech-20250430x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-006512
- JSON: https://secwatch.observer/filing/0001558370-25-006512.json
- Plain text: https://secwatch.observer/filing/0001558370-25-006512.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.